David Molter obtained his bachelor’s degree in biotechnology at the Bingen University of Applied Sciences in 2023. In the same year, he started the master’s program for synthetic biotechnology at the same university. For his master’s thesis he joined the Fraunhofer Institute for Microengineering and Microsystems at Mainz, where he developed and optimized a microfluidic platform for automated antibody staining of leukocytes as part of the Fraunhofer Lighthouse Project RNAuto. Since early 2026 he is a PhD student in the department for rheumatology and clinical immunology and investigates the circadian regulation of UV-induced disease activity in human systemic lupus erythematosus.